Dr. Kelly McNagny has been named a Co-Scientific Director of the Centre for Drug Research and Development (CDRD)—a national not-for-profit that speeds the development and commercialization of new drugs and health technologies emerging from Canada’s universities and research hospitals. Dr. …
AllerGen researcher Dr. Kelly McNagny named Co-Scientific Director of CDRD Read more »
AllerGen’s CHILD Study enables the microbiome research featured in “Say Hello to Your Little Friends” (Globe & Mail, June 8, 2015). The article profiles Dr. Brett Finlay, a microbiologist at The University of British Columbia, who uses CHILD Study data …
A new consensus communication—issued jointly by Canadian, American and European allergists and the World Allergy Organization—recommends introducing peanut-containing products into the diet of “high risk” infants between four and 11 months of age. The Canadian Society of Allergy & Clinical …
Canadian allergists recommend early peanut introduction for “high risk” infants Read more »
Dr. Catherine Laprise, a co-investigator with the Canadian Healthy Infant Longitudinal Development (CHILD) Study, spoke, in a French-language interview, with RadioCanada on May 23, 2015, to discuss how 3,500 Canadian families are helping scientists uncover the origins of asthma and …
Surfactant protein D (SP-D) is an important molecule in the lungs that protects lung cells from inhaled pollutants, microbes and allergens. In a new study published in Respiratory Research, AllerGen researchers report that SP-D in asthmatics differs from that found …
Study finds protein difference in lungs of asthmatics Read more »
Today’s Parent magazine (May 2015) provides a food allergy research “checkup” in its article “The Good News on Food Allergies.” In the article, researchers from AllerGen’s Canadian Healthy Infant Longitudinal Development (CHILD) Study and the Canadian Food Allergy Strategic Team …
Today’s Parent predicts “new hope for kids with serious food allergies” Read more »
AllerGen investigator Dr. Malcolm Sears has been honoured with an Award for Leadership in Health Research, presented by the Asthma Society of Canada (ASC). Dr. Sears is the Co-Director of AllerGen’s ground-breaking Canadian Healthy Infant Longitudinal Development (CHILD) Study, a …
CHILD Study Director Dr. Malcolm Sears honoured by the Asthma Society of Canada Read more »
A new study emerging from AllerGen’s Canadian Healthy Infant Longitudinal Development (CHILD) Study has revealed an association between sensitivity to allergens and exposure to traffic-related air pollution during infancy. The study, “Perinatal Exposure to Traffic-Related Air Pollution and Atopy at …
CHILD Study shows infant exposure to air pollution increases risk for allergies Read more »
The nasal allergen challenge (NAC) protocol developed by AllerGen’s Allergic Rhinitis – Clinical Investigator Collaborative (AR-CIC) is described in a new publication available from the website of Allergy, Asthma & Clinical Immunology (AACI), the official journal of the Canadian Society …
AllerGen’s Allergic Rhinitis CIC: optimizing a nasal allergen challenge protocol Read more »
An AllerGen-supported study, “Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy,” has found that children who are allergic to peanuts are more likely to be exposed to them in their own homes than at …
Allergic kids more likely to be exposed to peanut at home than at school Read more »
Dr. Paul O’Byrne, principal investigator for AllerGen’s Clinical Investigator Collaborative Legacy Project, Professor and Chair of Medicine at McMaster University, and Director of the Firestone Institute for Respiratory Health at St. Joseph’s Healthcare, is one of five faculty members just …
Head of AllerGen’s CIC honoured by McMaster University Read more »
AllerGen partner organization the Asthma Society of Canada is holding the event “Clearing the Air: Asthma and Allergies in a Time of Climate Change” on May 4 and 5, 2015, in Toronto, ON, to coincide with World Asthma Day. Motivated …